Analyze Diet
PeerJ2024; 12; e16832; doi: 10.7717/peerj.16832

Immortalization of American miniature horse-derived fibroblast by cell cycle regulator with normal karyotype.

Abstract: Immortalized cells serve as a crucial research tool that capitalizes on their robust proliferative properties for functional investigations of an organism. Establishing an immortalized American miniature horse cell line could yield valuable insights into these animals' genetic and physiological characteristics and susceptibility to health issues. To date, immortalized small horse cells with normal karyotypes have not been established. In this study, we successfully established primary and immortalized fibroblast cell lines through the combined expression of human-derived mutant cyclin-dependent kinase 4 (CDK4R24C), cyclin D1, and Telomerase Reverse Transcriptase (TERT), although CDK4R24C and cyclin D1, SV40T and TERT did not result in successful immortalization. Our comparison of the properties of these immortalized cells demonstrated that K4DT immortalized cells maintain a normal karyotype. Ultimately, our findings could pave the way for the development of targeted interventions to enhance the health and well-being of American miniature horses.
Publication Date: 2024-01-26 PubMed ID: 38288466PubMed Central: PMC10823992DOI: 10.7717/peerj.16832Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research has successfully created stable, continuously dividing ‘immortal’ cells from an American Miniature Horse using specific human-derived proteins. Immortalized cells like these can provide important insights into genetic and physiological characteristics of the animal.

Research Objective

The objective of this research was to establish a stable, ‘immortal’ cell line from fibroblasts (a common type of cell found in connective tissues) derived from an American Miniature Horse. These immortalized cells significantly contribute to ongoing research as they can proliferate indefinitely, providing important insights into the animal’s genetic and physiological traits.

Methodology

The researchers accomplished immortalization by expressing certain proteins in the horse cells. Specifically:

  • They used a mutated form of human-derived cyclin-dependent kinase 4 (CDK4R24C), along with cyclin D1 and Telomerase Reverse Transcriptase (TERT) — all crucial components in controlling cell division and longevity.
  • They also attempted to achieve immortalization using a combination of CDK4R24C, cyclin D1, SV40T (a viral protein), and TERT, but this approach was not successful.

Findings

Outcomes of the research were as follows:

  • The combination of CDK4R24C, cyclin D1, and TERT was successful in creating an immortalized fibroblast cell line from a miniature horse.
  • A key feature of these immortalized cells is that they maintained a normal karyotype, meaning the number and appearance of their chromosomes remain typical which is crucial to ensure that the cells behave and respond in a way similar to normal cells in the body.
  • The alternative combination including SV40T was not successful in immortalizing the cells.

Conclusion

The researchers managed to establish an immortalized cell line with a “normal” karyotype from an American miniature horse. This accomplishment opens the way for further research on these animals’ genetic and physiological traits, yielding potentially valuable information for targeted interventions to improve their health and well-being.

Cite This Article

APA
Tani T. (2024). Immortalization of American miniature horse-derived fibroblast by cell cycle regulator with normal karyotype. PeerJ, 12, e16832. https://doi.org/10.7717/peerj.16832

Publication

ISSN: 2167-8359
NlmUniqueID: 101603425
Country: United States
Language: English
Volume: 12
Pages: e16832

Researcher Affiliations

Tani, Tetsuya
  • Department of Advanced Bioscience, Kindai University, Nara, Nara, Japan.

MeSH Terms

  • Horses / genetics
  • Humans
  • Animals
  • United States
  • Cyclin D1 / genetics
  • Cell Line
  • Cell Cycle / genetics
  • Karyotype
  • Fibroblasts

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 35 references
  1. Virology. 1984 Sep;137(2):414-21
    pubmed: 6091337
  2. J Biotechnol. 2014 Apr 20;176:50-7
    pubmed: 24589663
  3. Clinics (Sao Paulo). 2021 Feb 05;76:e2432
    pubmed: 33567048
  4. J Cell Biochem. 2006 May 15;98(2):267-86
    pubmed: 16408275
  5. PLoS One. 2020 Mar 2;15(3):e0229996
    pubmed: 32119713
  6. Sci Rep. 2014 Feb 13;4:4089
    pubmed: 24522485
  7. PLoS One. 2019 Aug 26;14(8):e0221364
    pubmed: 31449544
  8. Reprod Domest Anim. 2008 Jul;43 Suppl 2:331-7
    pubmed: 18638143
  9. In Vitro Cell Dev Biol Anim. 2021 Dec;57(10):998-1005
    pubmed: 34888747
  10. Anticancer Res. 1996 Sep-Oct;16(5A):2681-6
    pubmed: 8917370
  11. J Neurosci Methods. 2009 Jan 30;176(2):112-20
    pubmed: 18822316
  12. BMC Cell Biol. 2007 Jun 01;8:20
    pubmed: 17543094
  13. Biol Proced Online. 2017 Oct 18;19:13
    pubmed: 29075153
  14. Oncogene. 1998 Mar 5;16(9):1217-22
    pubmed: 9528864
  15. EMBO J. 1989 Dec 1;8(12):3905-10
    pubmed: 2555178
  16. Oncogene. 2005 Nov 21;24(52):7729-45
    pubmed: 16299533
  17. Cytotechnology. 2018 Dec;70(6):1619-1630
    pubmed: 30225752
  18. Sci Rep. 2018 Jun 20;8(1):9229
    pubmed: 29925962
  19. Biochem Biophys Res Commun. 2000 Nov 30;278(3):503-10
    pubmed: 11095941
  20. Sci Rep. 2020 Dec 16;10(1):22047
    pubmed: 33328524
  21. Biol Reprod. 2002 Aug;67(2):442-6
    pubmed: 12135879
  22. Biochem Biophys Res Commun. 2020 May 14;525(4):1046-1053
    pubmed: 32178875
  23. Cytotechnology. 2016 Oct;68(5):1937-47
    pubmed: 27449922
  24. J Cell Physiol. 2019 May;234(5):6709-6720
    pubmed: 30417340
  25. Chromosoma. 2012 Oct;121(5):475-88
    pubmed: 22797876
  26. iScience. 2020 Dec 11;24(1):101929
    pubmed: 33437932
  27. Annu Rev Anim Biosci. 2016;4:223-53
    pubmed: 26566158
  28. J Reprod Dev. 2017 Jun 21;63(3):311-318
    pubmed: 28331164
  29. Cytotechnology. 2022 Feb;74(1):181-192
    pubmed: 35185293
  30. Nucleic Acids Res. 2020 Apr 17;48(7):3657-3677
    pubmed: 32128579
  31. Science. 1998 Dec 11;282(5396):2095-8
    pubmed: 9851933
  32. J Immunol. 2014 Jun 15;192(12):5933-42
    pubmed: 24799566
  33. Anim Genet. 2010 Dec;41 Suppl 2:159-65
    pubmed: 21070291
  34. Clin Immunol. 2022 May;238:108998
    pubmed: 35398286
  35. PeerJ. 2019 Sep 16;7:e7678
    pubmed: 31576240

Citations

This article has been cited 0 times.